Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
CRH
CRH
|
+$150M |
| 2 |
Kenvue
KVUE
|
+$98.9M |
| 3 |
Textron
TXT
|
+$50.7M |
| 4 |
Extra Space Storage
EXR
|
+$23.3M |
| 5 |
AngloGold Ashanti
AU
|
+$17.1M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.12B |
| 2 |
Microsoft
MSFT
|
+$890M |
| 3 |
Amazon
AMZN
|
+$463M |
| 4 |
NVIDIA
NVDA
|
+$425M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$316M |
Sector Composition
| 1 | Technology | 29.44% |
| 2 | Healthcare | 13.62% |
| 3 | Consumer Discretionary | 11.97% |
| 4 | Industrials | 9.13% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRI
2101
DELISTED
Atrion Corp
ATRI
| $1.28M | ﹤0.01% |
3,102
| – | – |
|
2102
Lufax Holding
LU
$2.54B
| $1.28M | ﹤0.01% |
301,525
| – | – |
|
|
SILK
2103
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.28M | ﹤0.01% |
85,200
+1,400
| +2% | +$21K |
|
2104
Guess, Inc.
GES
$868M
| $1.27M | ﹤0.01% |
58,900
-7,800
| -12% | -$169K |
|
2105
James River Group
JRVR
$246M
| $1.27M | ﹤0.01% |
82,699
+1,000
| +1% | +$15.4K |
|
2106
Enviri
NVRI
$959M
| $1.27M | ﹤0.01% |
175,300
+2,200
| +1% | +$15.9K |
|
|
VERV
2107
DELISTED
Verve Therapeutics
VERV
| $1.26M | ﹤0.01% |
95,300
+7,700
| +9% | +$102K |
|
2108
EchoStar
SATS
$23B
| $1.26M | ﹤0.01% |
75,400
+1,700
| +2% | +$28.5K |
|
2109
Open Lending Corp
LPRO
$253M
| $1.26M | ﹤0.01% |
172,450
+1,800
| +1% | +$13.2K |
|
2110
Heritage Financial
HFWA
$842M
| $1.26M | ﹤0.01% |
77,168
+1,400
| +2% | +$22.8K |
|
2111
Gray Television
GTN
$579M
| $1.26M | ﹤0.01% |
181,800
+4,900
| +3% | +$33.9K |
|
2112
European Wax Center
EWCZ
$161M
| $1.26M | ﹤0.01% |
77,600
+1,800
| +2% | +$29.2K |
|
2113
Health Catalyst
HCAT
$229M
| $1.25M | ﹤0.01% |
123,600
+2,100
| +2% | +$21.3K |
|
2114
Interface
TILE
$1.6B
| $1.25M | ﹤0.01% |
127,500
+1,900
| +2% | +$18.6K |
|
2115
Berry Corp
BRY
$251M
| $1.25M | ﹤0.01% |
152,500
+2,500
| +2% | +$20.5K |
|
2116
TELUS International
TIXT
$1.25B
| $1.25M | ﹤0.01% |
+162,900
| New | +$1.25M |
|
2117
Conduent
CNDT
$442M
| $1.24M | ﹤0.01% |
356,654
| – | – |
|
2118
Mesa Laboratories
MLAB
$327M
| $1.24M | ﹤0.01% |
11,802
+200
| +2% | +$21K |
|
2119
Target Hospitality
TH
$876M
| $1.24M | ﹤0.01% |
78,000
+1,200
| +2% | +$19.1K |
|
2120
RxSight
RXST
$410M
| $1.24M | ﹤0.01% |
44,400
| – | – |
|
2121
Vitesse Energy
VTS
$999M
| $1.23M | ﹤0.01% |
53,844
+4,100
| +8% | +$93.8K |
|
2122
OrthoPediatrics
KIDS
$484M
| $1.23M | ﹤0.01% |
38,500
+900
| +2% | +$28.8K |
|
2123
Myers Industries
MYE
$602M
| $1.23M | ﹤0.01% |
68,700
+1,000
| +1% | +$17.9K |
|
|
GMRE
2124
Global Medical REIT
GMRE
$511M
| $1.23M | ﹤0.01% |
136,800
+2,400
| +2% | +$21.5K |
|
2125
Ducommun
DCO
$1.36B
| $1.23M | ﹤0.01% |
28,200
+600
| +2% | +$26.1K |
|